Screening Nature Bank Isolates for Activity Against Mycobacterium Tuberculosis

Status
Completed
Start date
End date
Start stage
Screening
End stage
Hit ID
Asset
Natural Products and Bioaffinity Screening
Disease
Tuberculosis
Research areas
Drug

AstraZeneca scientists were interested in screening natural products for activity against M. tuberculosis. BVGH connected AstraZeneca with Dr. Quinn, who provided AstraZeneca with the GRIDD Nature Bank Fraction Library for their screening assays.